Target intelligence / Profile preview

Organic cation transporter 1, Organic cation transporter 2, Organic cation transporter 3 (OCT1, OCT2, OCT3)

Target
OCT1, OCT2, OCT3
Molecular classification
Transporter, Membrane protein, Solute carrier (SLC22) family member
01

Overview

Organic cation transporter 1, 2, and 3 (OCT1, OCT2, and OCT3) are members of the solute carrier family 22 (SLC22) of membrane proteins. They are polyspecific transporters responsible for the uptake and clearance of a wide variety of endogenous amines (e.g., choline, monoamines) and diverse cationic drugs from blood into tissues including the liver, kidney, and brain. OCT1 is primarily expressed in the liver, OCT2 in the kidney, and OCT3 in many tissues including heart, brain, and placenta. Their broad substrate specificity and high expression make them key determinants of drug absorption, distribution, elimination, and drug-drug interactions. Genetic and functional variations in these transporters can have major consequences for drug efficacy, adverse reactions, and toxicity profiles. They are therefore considered clinically important drug transporters and therapeutic modulation or inhibition of their function can have significant pharmacological and toxicological implications

Other names
SLC22A1 (OCT1)SLC22A2 (OCT2)SLC22A3 (OCT3)organic cation transporter(s)polyspecific organic cation transporter(s)
02

Mechanism of action

Substrate drugs are transported across cell membranes via electrogenic facilitated diffusion - Inhibitors block substrate binding or transporter conformational changes, reducing uptake

03

Biological functions

Transmembrane transport of endogenous and exogenous organic cationsRegulation of drug absorption, distribution, and excretionUptake of neurotransmitters and metabolitesModulation of drug pharmacokinetics and elimination
04

Disease associations

Cancer (altered expression linked to drug resistance)Kidney disease (influences nephrotoxicity of drugs)Liver disease (impacts hepatotoxicity of drugs)Adverse drug reactions (through altered drug handling)Other (genetic variations affect drug efficacy and toxicity)
05

Safety considerations

Risk of drug-drug interactions leading to altered efficacy or toxicityGenetic variability contributing to unpredictable drug responseAccumulation or impaired clearance of cationic drugs, contributing to nephrotoxicity or hepatotoxicity
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Genetic polymorphisms in SLC22A1, SLC22A2, and SLC22A3 may serve as biomarkers for drug response and toxicity

Beyond the preview

Go deeper on Organic cation transporter 1, Organic cation transporter 2, Organic cation transporter 3 (OCT1, OCT2, OCT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organic cation transporter 1, Organic cation transporter 2, Organic cation transporter 3 (OCT1, OCT2, OCT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call